Home Cart Sign in  
Chemical Structure| 73069-14-4 Chemical Structure| 73069-14-4

Structure of Atractylenolide II
CAS No.: 73069-14-4

Chemical Structure| 73069-14-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Atractylenolide II is a sesquiterpene compound isolated from the dried rhizome of Atractylodes macrocephala (Baizhu in Chinese) with anti-proliferative activity.

Synonyms: Asterolide; 2-Atractylenolide

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Atractylenolide II

CAS No. :73069-14-4
Formula : C15H20O2
M.W : 232.32
SMILES Code : O=C1C(C)=C(C[C@@]23[H])[C@@](C[C@@]3(C)CCCC2=C)([H])O1
Synonyms :
Asterolide; 2-Atractylenolide
MDL No. :MFCD09037396

Safety of Atractylenolide II

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Atractylenolide II

Hedgehog

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
GES-1 cells 400 μM 48 h no cytotoxicity Molecules. 2017 Nov 3;22(11):1886
AGS cells 400 μM 48 h significantly inhibited cell proliferation and induced apoptosis Molecules. 2017 Nov 3;22(11):1886
AN3CA cells 0, 25, 50, 100, 200, 400 µM 24, 48, 72 h Inhibited cell proliferation and glycolysis, induced apoptosis Molecules. 2024 Feb 21;29(5):939
HCT15 cells 80 μM 24 h AT-II significantly inhibited the growth and migration abilities of HCT15 cells, with enhanced effects when combined with IFN-γ. J Cancer. 2024 Jun 11;15(13):4328-4344
HT29 cells 80 μM 24 h AT-II significantly inhibited the growth and migration abilities of HT29 cells, with enhanced effects when combined with IFN-γ. J Cancer. 2024 Jun 11;15(13):4328-4344
Lovo cells 50 μg/mL 48 h Atractylenolide II significantly inhibited the proliferation and viability of Lovo cells and enhanced their sensitivity to 5-fluorouracil, mitomycin, adriamycin, and cisplatin. J Cell Mol Med. 2019 May;23(5):3151-3165
SW480 cells 50 μg/mL 48 h Atractylenolide II significantly inhibited the proliferation and viability of SW480 cells and enhanced their sensitivity to 5-fluorouracil, mitomycin, adriamycin, and cisplatin. J Cell Mol Med. 2019 May;23(5):3151-3165

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice and C57BL/6 mice Colorectal cancer xenograft model and lung metastasis model Intraperitoneal injection 50 mg/kg Once daily for 21 days AT-II alone or in combination with IFN-γ significantly inhibited tumor growth and lung metastasis, and improved the tumor microenvironment. J Cancer. 2024 Jun 11;15(13):4328-4344

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.30mL

0.86mL

0.43mL

21.52mL

4.30mL

2.15mL

43.04mL

8.61mL

4.30mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories